(Q39542838)

12 September 2017

title

Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir (English)

1 reference

12 September 2017

1 reference

Feline leukemia virus

object named as

Feline leukemia virus

1 reference

1

1 reference

12 September 2017

Beatrice Weibel

2

1 reference

12 September 2017

Hans Lutz

series ordinal

3

1 reference

12 September 2017

publication date

12 April 2011

1 reference

12 September 2017

published in

Veterinary Microbiology

1 reference

12 September 2017

volume

152

1 reference

12 September 2017

issue

1-2

1 reference

12 September 2017

page(s)

165-168

1 reference

Feline immunodeficiency virus, feline leukemia virus and Toxoplasma gondii in stray and household cats in Kerman-Iran: seroprevalence and correlation with clinical and laboratory findings

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Seroprevalence of viral infections in domestic cats in Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Survey of infectious and parasitic diseases in stray cats at the Lisbon Metropolitan Area, Portugal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Fecal shedding of infectious feline leukemia virus and its nucleic acids: a transmission potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

How molecular methods change our views of FeLV infection and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Differential sensitivities of retroviruses to integrase strand transfer inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Feline leukaemia. ABCD guidelines on prevention and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Novel integrase inhibitors for HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2011.03.039

10.1016/J.VETMIC.2011.03.039

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference